2 reports of this reaction
1.2% of all AVENA SATIVA FLOWERING TOP reports
#20 most reported adverse reaction
BLOOD ALKALINE PHOSPHATASE INCREASED is the #20 most commonly reported adverse reaction for AVENA SATIVA FLOWERING TOP. There are 2 FDA adverse event reports linking AVENA SATIVA FLOWERING TOP to BLOOD ALKALINE PHOSPHATASE INCREASED. This represents approximately 1.2% of all 168 adverse event reports for this drug.
Patients taking AVENA SATIVA FLOWERING TOP who experience blood alkaline phosphatase increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD ALKALINE PHOSPHATASE INCREASED is a less commonly reported adverse event for AVENA SATIVA FLOWERING TOP, but still significant enough to appear in the safety profile.
In addition to blood alkaline phosphatase increased, the following adverse reactions have been reported for AVENA SATIVA FLOWERING TOP:
The following drugs have also been linked to blood alkaline phosphatase increased in FDA adverse event reports:
BLOOD ALKALINE PHOSPHATASE INCREASED has been reported as an adverse event in 2 FDA reports for AVENA SATIVA FLOWERING TOP. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD ALKALINE PHOSPHATASE INCREASED accounts for approximately 1.2% of all adverse event reports for AVENA SATIVA FLOWERING TOP, making it a notable side effect.
If you experience blood alkaline phosphatase increased while taking AVENA SATIVA FLOWERING TOP, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.